FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (Kreitchman PET Center)

View source ↗

Summary

The FDA approved Fludeoxyglucose F18 through an Original Application filed by Kreitchman PET Center for use as a radiopharmaceutical in PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cancer
• Ischemic Heart Disease

Drugs mentioned

• Fludeoxyglucose F18 (Fludeoxyglucose F18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18)